Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Shanghai Pharma Signs MOU to Run China Phase III Trial of Korean Alzheimer’s Drug

publication date: Sep 14, 2023

Shanghai Pharmaceuticals signed an MOU with Korea’s AriBio to jointly conduct the China arm of a global Phase III trial of a therapy for mild Alzheimer’s disease. AriBio’s AR1001 is a selective inhibitor of phosphodiesterase 5 (PDE5) that is designed to inhibit neuron apoptosis and restore synaptic plasticity. If the drug is approved, Shanghai Pharma will have distribution and manufacturing rights for the candidate in China. In a Phase II trial, AR1001 was safe, and it showed efficacy, especially if patients were not taking other Alzheimer's medications, such as Aricept. More details....

Stock Symbols: (SHA: 601607; HK: 2607)

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

Upcoming Events

ChinaBio® Partnering Forum
September 10–11, 2024 | Shanghai, China
Register here

BIO-Europe®
November 4–6, 2024 | Stockholm, Sweden
Save €900 before September 13!
Register here

Biotech Showcase™
January 13–15, 2025 | San Francisco, CA
Save $600 before September 27!
Other Relevant Events

Antibody Engineering & Therapeutics Asia
October 21–23, 2024 | Kyoto, Japan
Save 30% with code CHINABIO30!
Register here